| scholarly article | Q13442814 |
| P2093 | author name string | Po-Huang Lee | |
| Huan-Yao Lei | |||
| Yi-Lin Chen | |||
| Steven K Takemoto | |||
| Paul I Terasaki | |||
| Chung-Jye Hung | |||
| Po-Chang Lee | |||
| Alen Tsai | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1192-1194 | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies | |
| P478 | volume | 74 |
| Q35575249 | Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease |
| Q36131185 | Antibody-mediated rejection of single class I MHC-disparate cardiac allografts |
| Q36666906 | Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation |
| Q39101892 | B Cell Immunity in Solid Organ Transplantation. |
| Q33723769 | B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans |
| Q47762688 | Binding of anti-HLA class I antibody to endothelial cells produce an inflammatory cytokine secretory pattern |
| Q33584895 | Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial |
| Q43239536 | Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help. |
| Q26775103 | Chronic Renal Transplant Rejection and Possible Anti-Proliferative Drug Targets |
| Q37394650 | Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses |
| Q34080938 | Clinical outcomes among renal transplant recipients with pre-transplant weakly reactive donor-specific antibodies |
| Q38409644 | Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody in kidney transplant recipients with allograft dysfunction |
| Q33441520 | Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities |
| Q33867260 | Development of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I-related chain A and are significantly associated with development of chronic rejection after human lung transplantation |
| Q92803508 | Donor-Specific Antibodies in the Absence of Rejection Are Not a Risk Factor for Allograft Failure |
| Q85084898 | Donor-specific HLA antibodies and graft function in children after renal transplantation |
| Q37934146 | Experimental models of B cell tolerance in transplantation |
| Q37485481 | Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys |
| Q34534928 | Genotypic diversity of complement component C4 does not predict kidney transplant outcome |
| Q36751659 | HLA antibody analysis: sensitivity, specificity, and clinical significance in solid organ transplantation |
| Q36202286 | Human leukocyte antigen antibodies for monitoring transplant patients |
| Q37375622 | Incidence and clinical significance of de novo donor specific antibodies after kidney transplantation |
| Q37552423 | Kidney paired donation in the presence of donor-specific antibodies |
| Q27006030 | Late and chronic antibody-mediated rejection: main barrier to long term graft survival |
| Q35153318 | Late kidney allograft loss: what we know about it, and what we can do about it |
| Q33974428 | Long-Term Effects of Antibodies against Human Leukocyte Antigens Detected by Flow Cytometry in the First Year after Renal Transplantation |
| Q33574621 | MICA diversity and linkage disequilibrium with HLA-B alleles in renal-transplant candidates in southern Brazil |
| Q64252507 | Metabolomics Approaches for the Diagnosis and Understanding of Kidney Diseases |
| Q39217968 | Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection |
| Q37723175 | Prevalence and risk factors for early chronic allograft nephropathy in a live related renal transplant program |
| Q36913888 | Red blood cell transfusion risks in patients with end-stage renal disease |
| Q80373591 | Reduction of human anti-tetanus toxoid antibody in hu-PBL-SCID mice by immunodominant peptides of tetanus toxoid |
| Q41810263 | Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy |
| Q64982205 | Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy. |
| Q37300446 | Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes |
| Q54979506 | SYK Inhibition Induces Apoptosis in Germinal Center-Like B Cells by Modulating the Antiapoptotic Protein Myeloid Cell Leukemia-1, Affecting B-Cell Activation and Antibody Production. |
| Q49521510 | The Role of the Endothelium during Antibody-Mediated Rejection: From Victim to Accomplice |
| Q37586853 | The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept. |
| Q35223952 | The link between major histocompatibility complex antibodies and cell proliferation |
| Q33891696 | The role of B cells in solid organ transplantation. |
| Q37363951 | The role of antibodies in transplantation |
| Q38048605 | The role of complement in antibody-mediated rejection in kidney transplantation |
| Q38151921 | The specificity of acute and chronic microvascular alterations in renal allografts |
| Q36054757 | The spleen is the major source of antidonor antibody-secreting cells in murine heart allograft recipients |
| Q33944422 | Tolerance to noninherited maternal antigens in mice and humans |
| Q27021397 | Treatment options and strategies for antibody mediated rejection after renal transplantation |
| Q28069336 | Unraveling the Role of Allo-Antibodies and Transplant Injury |
| Q27024077 | Vascular endothelium as a target of immune response in renal transplant rejection |
| Q79979170 | [Alloantibodies-mediated kidney transplant rejection: a pair of continuing approaches, and with nonetheless many open questions] |
Search more.